DEOXY RISEDRONIC ACID

OP(O)(=O)C(CC1=CN=CC=C1)P(O)(O)=O

InChIKey=KZMOFWIRXNQJET-UHFFFAOYSA-N

InChI=1S/C7H11NO6P2/c9-15(10,11)7(16(12,13)14)4-6-2-1-3-8-5-6/h1-3,5,7H,4H2,(H2,9,10,11)(H2,12,13,14)

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Targets

Primary Target	Pharmacology	Condition	Potency
Farnesyl diphosphate synthase 28 Target ID: CHEMBL1782 Sources: https://www.ncbi.nlm.nih.gov/pubmed/18327899	Inhibitor 8504		33.0 nM [IC50]

PubMed

Title	Date	PubMed
Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.	2008-04-10	18327899

Substance Class	Chemical Created by `admin` on `Mon Mar 31 22:32:11 GMT 2025` Edited by `admin` on `Mon Mar 31 22:32:11 GMT 2025`
Record UNII	KU59Z0XVL4
Record Status	`Validated (UNII)`
Record Version

Name

Type

Language

DEOXY RISEDRONIC ACID

Common Name

English

RISEDRONATE RELATED COMPOUND C

Preferred Name

English

PHOSPHONIC ACID, P,P'-(2-(3-PYRIDINYL)ETHYLIDENE)BIS-

Systematic Name

English

RISEDRONATE RELATED COMPOUND C [USP-RS]

Common Name

English

(2-(PYRIDIN-3-YL)ETHYLIDENE)BIS(PHOSPHONIC ACID)

Systematic Name

English

RISEDRONATE SODIUM 2.5-HYDRATE IMPURITY E [EP IMPURITY]

Common Name

English

RISEDRONATE RELATED COMPOUND C [USP IMPURITY]

Common Name

English

Code System Code Type Description

FDA UNII

KU59Z0XVL4